The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Nanoparticle Drug Delivery Systems Market Research Report 2025
Synopsis
Nanoparticle drug delivery systems are engineered technologies that use nanoparticles for the targeted delivery and controlled release of therapeutic agents. The modern form of a drug delivery system should minimize side-effects and reduce both dosage and dosage frequency. Recently, nanoparticles have aroused attention due to their potential application for effective drug delivery.
In this report, we only study liposomal/lipid nanoparticle drug delivery system.
LNPs became more widely known in late 2020, as some COVID-19 vaccines that use RNA vaccine technology coat the fragile mRNA strands with PEGylated lipid nanoparticles as their delivery vehicle (including both the Moderna and the Pfizer–BioNTech COVID-19 vaccines).
In this report, the COVID-19 vaccines with lipid nanoparticles technologies are not covered. The COVID-19 vaccines launch on the end of 2020. We expect revenue for COVID-19 vaccines with lipid nanoparticles technologies in 2021 to be approximately 37 billion USD.
The global Nanoparticle Drug Delivery Systems market was valued at US$ 4571.7 million in 2023 and is anticipated to reach US$ 8891.1 million by 2030, witnessing a CAGR of 10.0% during the forecast period 2024-2030.
Global Nanoparticle Drug Delivery Systems key players include Gilead Sciences, CSPC, Pacira, Alnylam, etc. Global top four manufacturers hold a share about 37%.
Asia-Pacific is the largest market, with a share about 37%, followed by Europe, and North America, both have a share over 56 percent.
In terms of product, Liposomes Drugs is the largest segment, with a share over 92%. And in terms of application, the largest application is Retail Pharmacy, followed by Hospital, etc.
This report aims to provide a comprehensive presentation of the global market for Nanoparticle Drug Delivery Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nanoparticle Drug Delivery Systems.
Report Scope
The Nanoparticle Drug Delivery Systems market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nanoparticle Drug Delivery Systems market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nanoparticle Drug Delivery Systems companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Johnson & Johnson
Sun Pharmaceutical
CSPC
Kinyond
Teva
Fudan-Zhangjiang
Zydus Cadila
TTY Biopharma
Pacira
Luye Pharma
Leadiant Biosciences
Ipsen
Sayre Therapeutics
Jazz
Alnylam
Bausch Health
Acrotech Biopharma
Takeda
Chiesi Farmaceutici
Gilead Sciences
Segment by Type
Liposomes Drugs
Lipid Nanoparticle Drugs
Segment by Application
Hospital
Retail Pharmacy
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nanoparticle Drug Delivery Systems companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Nanoparticle drug delivery systems are engineered technologies that use nanoparticles for the targeted delivery and controlled release of therapeutic agents. The modern form of a drug delivery system should minimize side-effects and reduce both dosage and dosage frequency. Recently, nanoparticles have aroused attention due to their potential application for effective drug delivery.
In this report, we only study liposomal/lipid nanoparticle drug delivery system.
LNPs became more widely known in late 2020, as some COVID-19 vaccines that use RNA vaccine technology coat the fragile mRNA strands with PEGylated lipid nanoparticles as their delivery vehicle (including both the Moderna and the Pfizer–BioNTech COVID-19 vaccines).
In this report, the COVID-19 vaccines with lipid nanoparticles technologies are not covered. The COVID-19 vaccines launch on the end of 2020. We expect revenue for COVID-19 vaccines with lipid nanoparticles technologies in 2021 to be approximately 37 billion USD.
The global Nanoparticle Drug Delivery Systems market was valued at US$ 4571.7 million in 2023 and is anticipated to reach US$ 8891.1 million by 2030, witnessing a CAGR of 10.0% during the forecast period 2024-2030.
Global Nanoparticle Drug Delivery Systems key players include Gilead Sciences, CSPC, Pacira, Alnylam, etc. Global top four manufacturers hold a share about 37%.
Asia-Pacific is the largest market, with a share about 37%, followed by Europe, and North America, both have a share over 56 percent.
In terms of product, Liposomes Drugs is the largest segment, with a share over 92%. And in terms of application, the largest application is Retail Pharmacy, followed by Hospital, etc.
This report aims to provide a comprehensive presentation of the global market for Nanoparticle Drug Delivery Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nanoparticle Drug Delivery Systems.
Report Scope
The Nanoparticle Drug Delivery Systems market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nanoparticle Drug Delivery Systems market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nanoparticle Drug Delivery Systems companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Johnson & Johnson
Sun Pharmaceutical
CSPC
Kinyond
Teva
Fudan-Zhangjiang
Zydus Cadila
TTY Biopharma
Pacira
Luye Pharma
Leadiant Biosciences
Ipsen
Sayre Therapeutics
Jazz
Alnylam
Bausch Health
Acrotech Biopharma
Takeda
Chiesi Farmaceutici
Gilead Sciences
Segment by Type
Liposomes Drugs
Lipid Nanoparticle Drugs
Segment by Application
Hospital
Retail Pharmacy
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nanoparticle Drug Delivery Systems companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nanoparticle Drug Delivery Systems Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Liposomes Drugs
1.2.3 Lipid Nanoparticle Drugs
1.3 Market by Application
1.3.1 Global Nanoparticle Drug Delivery Systems Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Nanoparticle Drug Delivery Systems Market Perspective (2019-2030)
2.2 Nanoparticle Drug Delivery Systems Growth Trends by Region
2.2.1 Global Nanoparticle Drug Delivery Systems Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Nanoparticle Drug Delivery Systems Historic Market Size by Region (2019-2024)
2.2.3 Nanoparticle Drug Delivery Systems Forecasted Market Size by Region (2025-2030)
2.3 Nanoparticle Drug Delivery Systems Market Dynamics
2.3.1 Nanoparticle Drug Delivery Systems Industry Trends
2.3.2 Nanoparticle Drug Delivery Systems Market Drivers
2.3.3 Nanoparticle Drug Delivery Systems Market Challenges
2.3.4 Nanoparticle Drug Delivery Systems Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nanoparticle Drug Delivery Systems Players by Revenue
3.1.1 Global Top Nanoparticle Drug Delivery Systems Players by Revenue (2019-2024)
3.1.2 Global Nanoparticle Drug Delivery Systems Revenue Market Share by Players (2019-2024)
3.2 Global Nanoparticle Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Nanoparticle Drug Delivery Systems Revenue
3.4 Global Nanoparticle Drug Delivery Systems Market Concentration Ratio
3.4.1 Global Nanoparticle Drug Delivery Systems Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nanoparticle Drug Delivery Systems Revenue in 2023
3.5 Nanoparticle Drug Delivery Systems Key Players Head office and Area Served
3.6 Key Players Nanoparticle Drug Delivery Systems Product Solution and Service
3.7 Date of Enter into Nanoparticle Drug Delivery Systems Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Nanoparticle Drug Delivery Systems Breakdown Data by Type
4.1 Global Nanoparticle Drug Delivery Systems Historic Market Size by Type (2019-2024)
4.2 Global Nanoparticle Drug Delivery Systems Forecasted Market Size by Type (2025-2030)
5 Nanoparticle Drug Delivery Systems Breakdown Data by Application
5.1 Global Nanoparticle Drug Delivery Systems Historic Market Size by Application (2019-2024)
5.2 Global Nanoparticle Drug Delivery Systems Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Nanoparticle Drug Delivery Systems Market Size (2019-2030)
6.2 North America Nanoparticle Drug Delivery Systems Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Nanoparticle Drug Delivery Systems Market Size by Country (2019-2024)
6.4 North America Nanoparticle Drug Delivery Systems Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Nanoparticle Drug Delivery Systems Market Size (2019-2030)
7.2 Europe Nanoparticle Drug Delivery Systems Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Nanoparticle Drug Delivery Systems Market Size by Country (2019-2024)
7.4 Europe Nanoparticle Drug Delivery Systems Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Nanoparticle Drug Delivery Systems Market Size (2019-2030)
8.2 Asia-Pacific Nanoparticle Drug Delivery Systems Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Nanoparticle Drug Delivery Systems Market Size by Region (2019-2024)
8.4 Asia-Pacific Nanoparticle Drug Delivery Systems Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Nanoparticle Drug Delivery Systems Market Size (2019-2030)
9.2 Latin America Nanoparticle Drug Delivery Systems Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Nanoparticle Drug Delivery Systems Market Size by Country (2019-2024)
9.4 Latin America Nanoparticle Drug Delivery Systems Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nanoparticle Drug Delivery Systems Market Size (2019-2030)
10.2 Middle East & Africa Nanoparticle Drug Delivery Systems Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Nanoparticle Drug Delivery Systems Market Size by Country (2019-2024)
10.4 Middle East & Africa Nanoparticle Drug Delivery Systems Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Detail
11.1.2 Johnson & Johnson Business Overview
11.1.3 Johnson & Johnson Nanoparticle Drug Delivery Systems Introduction
11.1.4 Johnson & Johnson Revenue in Nanoparticle Drug Delivery Systems Business (2019-2024)
11.1.5 Johnson & Johnson Recent Development
11.2 Sun Pharmaceutical
11.2.1 Sun Pharmaceutical Company Detail
11.2.2 Sun Pharmaceutical Business Overview
11.2.3 Sun Pharmaceutical Nanoparticle Drug Delivery Systems Introduction
11.2.4 Sun Pharmaceutical Revenue in Nanoparticle Drug Delivery Systems Business (2019-2024)
11.2.5 Sun Pharmaceutical Recent Development
11.3 CSPC
11.3.1 CSPC Company Detail
11.3.2 CSPC Business Overview
11.3.3 CSPC Nanoparticle Drug Delivery Systems Introduction
11.3.4 CSPC Revenue in Nanoparticle Drug Delivery Systems Business (2019-2024)
11.3.5 CSPC Recent Development
11.4 Kinyond
11.4.1 Kinyond Company Detail
11.4.2 Kinyond Business Overview
11.4.3 Kinyond Nanoparticle Drug Delivery Systems Introduction
11.4.4 Kinyond Revenue in Nanoparticle Drug Delivery Systems Business (2019-2024)
11.4.5 Kinyond Recent Development
11.5 Teva
11.5.1 Teva Company Detail
11.5.2 Teva Business Overview
11.5.3 Teva Nanoparticle Drug Delivery Systems Introduction
11.5.4 Teva Revenue in Nanoparticle Drug Delivery Systems Business (2019-2024)
11.5.5 Teva Recent Development
11.6 Fudan-Zhangjiang
11.6.1 Fudan-Zhangjiang Company Detail
11.6.2 Fudan-Zhangjiang Business Overview
11.6.3 Fudan-Zhangjiang Nanoparticle Drug Delivery Systems Introduction
11.6.4 Fudan-Zhangjiang Revenue in Nanoparticle Drug Delivery Systems Business (2019-2024)
11.6.5 Fudan-Zhangjiang Recent Development
11.7 Zydus Cadila
11.7.1 Zydus Cadila Company Detail
11.7.2 Zydus Cadila Business Overview
11.7.3 Zydus Cadila Nanoparticle Drug Delivery Systems Introduction
11.7.4 Zydus Cadila Revenue in Nanoparticle Drug Delivery Systems Business (2019-2024)
11.7.5 Zydus Cadila Recent Development
11.8 TTY Biopharma
11.8.1 TTY Biopharma Company Detail
11.8.2 TTY Biopharma Business Overview
11.8.3 TTY Biopharma Nanoparticle Drug Delivery Systems Introduction
11.8.4 TTY Biopharma Revenue in Nanoparticle Drug Delivery Systems Business (2019-2024)
11.8.5 TTY Biopharma Recent Development
11.9 Pacira
11.9.1 Pacira Company Detail
11.9.2 Pacira Business Overview
11.9.3 Pacira Nanoparticle Drug Delivery Systems Introduction
11.9.4 Pacira Revenue in Nanoparticle Drug Delivery Systems Business (2019-2024)
11.9.5 Pacira Recent Development
11.10 Luye Pharma
11.10.1 Luye Pharma Company Detail
11.10.2 Luye Pharma Business Overview
11.10.3 Luye Pharma Nanoparticle Drug Delivery Systems Introduction
11.10.4 Luye Pharma Revenue in Nanoparticle Drug Delivery Systems Business (2019-2024)
11.10.5 Luye Pharma Recent Development
11.11 Leadiant Biosciences
11.11.1 Leadiant Biosciences Company Detail
11.11.2 Leadiant Biosciences Business Overview
11.11.3 Leadiant Biosciences Nanoparticle Drug Delivery Systems Introduction
11.11.4 Leadiant Biosciences Revenue in Nanoparticle Drug Delivery Systems Business (2019-2024)
11.11.5 Leadiant Biosciences Recent Development
11.12 Ipsen
11.12.1 Ipsen Company Detail
11.12.2 Ipsen Business Overview
11.12.3 Ipsen Nanoparticle Drug Delivery Systems Introduction
11.12.4 Ipsen Revenue in Nanoparticle Drug Delivery Systems Business (2019-2024)
11.12.5 Ipsen Recent Development
11.13 Sayre Therapeutics
11.13.1 Sayre Therapeutics Company Detail
11.13.2 Sayre Therapeutics Business Overview
11.13.3 Sayre Therapeutics Nanoparticle Drug Delivery Systems Introduction
11.13.4 Sayre Therapeutics Revenue in Nanoparticle Drug Delivery Systems Business (2019-2024)
11.13.5 Sayre Therapeutics Recent Development
11.14 Jazz
11.14.1 Jazz Company Detail
11.14.2 Jazz Business Overview
11.14.3 Jazz Nanoparticle Drug Delivery Systems Introduction
11.14.4 Jazz Revenue in Nanoparticle Drug Delivery Systems Business (2019-2024)
11.14.5 Jazz Recent Development
11.15 Alnylam
11.15.1 Alnylam Company Detail
11.15.2 Alnylam Business Overview
11.15.3 Alnylam Nanoparticle Drug Delivery Systems Introduction
11.15.4 Alnylam Revenue in Nanoparticle Drug Delivery Systems Business (2019-2024)
11.15.5 Alnylam Recent Development
11.16 Bausch Health
11.16.1 Bausch Health Company Detail
11.16.2 Bausch Health Business Overview
11.16.3 Bausch Health Nanoparticle Drug Delivery Systems Introduction
11.16.4 Bausch Health Revenue in Nanoparticle Drug Delivery Systems Business (2019-2024)
11.16.5 Bausch Health Recent Development
11.17 Acrotech Biopharma
11.17.1 Acrotech Biopharma Company Detail
11.17.2 Acrotech Biopharma Business Overview
11.17.3 Acrotech Biopharma Nanoparticle Drug Delivery Systems Introduction
11.17.4 Acrotech Biopharma Revenue in Nanoparticle Drug Delivery Systems Business (2019-2024)
11.17.5 Acrotech Biopharma Recent Development
11.18 Takeda
11.18.1 Takeda Company Detail
11.18.2 Takeda Business Overview
11.18.3 Takeda Nanoparticle Drug Delivery Systems Introduction
11.18.4 Takeda Revenue in Nanoparticle Drug Delivery Systems Business (2019-2024)
11.18.5 Takeda Recent Development
11.19 Chiesi Farmaceutici
11.19.1 Chiesi Farmaceutici Company Detail
11.19.2 Chiesi Farmaceutici Business Overview
11.19.3 Chiesi Farmaceutici Nanoparticle Drug Delivery Systems Introduction
11.19.4 Chiesi Farmaceutici Revenue in Nanoparticle Drug Delivery Systems Business (2019-2024)
11.19.5 Chiesi Farmaceutici Recent Development
11.20 Gilead Sciences
11.20.1 Gilead Sciences Company Detail
11.20.2 Gilead Sciences Business Overview
11.20.3 Gilead Sciences Nanoparticle Drug Delivery Systems Introduction
11.20.4 Gilead Sciences Revenue in Nanoparticle Drug Delivery Systems Business (2019-2024)
11.20.5 Gilead Sciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Nanoparticle Drug Delivery Systems Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Liposomes Drugs
Table 3. Key Players of Lipid Nanoparticle Drugs
Table 4. Global Nanoparticle Drug Delivery Systems Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Nanoparticle Drug Delivery Systems Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Nanoparticle Drug Delivery Systems Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Nanoparticle Drug Delivery Systems Market Share by Region (2019-2024)
Table 8. Global Nanoparticle Drug Delivery Systems Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Nanoparticle Drug Delivery Systems Market Share by Region (2025-2030)
Table 10. Nanoparticle Drug Delivery Systems Market Trends
Table 11. Nanoparticle Drug Delivery Systems Market Drivers
Table 12. Nanoparticle Drug Delivery Systems Market Challenges
Table 13. Nanoparticle Drug Delivery Systems Market Restraints
Table 14. Global Nanoparticle Drug Delivery Systems Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Nanoparticle Drug Delivery Systems Market Share by Players (2019-2024)
Table 16. Global Top Nanoparticle Drug Delivery Systems Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nanoparticle Drug Delivery Systems as of 2023)
Table 17. Ranking of Global Top Nanoparticle Drug Delivery Systems Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Nanoparticle Drug Delivery Systems Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Nanoparticle Drug Delivery Systems Product Solution and Service
Table 21. Date of Enter into Nanoparticle Drug Delivery Systems Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Nanoparticle Drug Delivery Systems Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Nanoparticle Drug Delivery Systems Revenue Market Share by Type (2019-2024)
Table 25. Global Nanoparticle Drug Delivery Systems Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Nanoparticle Drug Delivery Systems Revenue Market Share by Type (2025-2030)
Table 27. Global Nanoparticle Drug Delivery Systems Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Nanoparticle Drug Delivery Systems Revenue Market Share by Application (2019-2024)
Table 29. Global Nanoparticle Drug Delivery Systems Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Nanoparticle Drug Delivery Systems Revenue Market Share by Application (2025-2030)
Table 31. North America Nanoparticle Drug Delivery Systems Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Nanoparticle Drug Delivery Systems Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Nanoparticle Drug Delivery Systems Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Nanoparticle Drug Delivery Systems Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Nanoparticle Drug Delivery Systems Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Nanoparticle Drug Delivery Systems Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Nanoparticle Drug Delivery Systems Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Nanoparticle Drug Delivery Systems Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Nanoparticle Drug Delivery Systems Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Nanoparticle Drug Delivery Systems Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Nanoparticle Drug Delivery Systems Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Nanoparticle Drug Delivery Systems Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Nanoparticle Drug Delivery Systems Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Nanoparticle Drug Delivery Systems Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Nanoparticle Drug Delivery Systems Market Size by Country (2025-2030) & (US$ Million)
Table 46. Johnson & Johnson Company Detail
Table 47. Johnson & Johnson Business Overview
Table 48. Johnson & Johnson Nanoparticle Drug Delivery Systems Product
Table 49. Johnson & Johnson Revenue in Nanoparticle Drug Delivery Systems Business (2019-2024) & (US$ Million)
Table 50. Johnson & Johnson Recent Development
Table 51. Sun Pharmaceutical Company Detail
Table 52. Sun Pharmaceutical Business Overview
Table 53. Sun Pharmaceutical Nanoparticle Drug Delivery Systems Product
Table 54. Sun Pharmaceutical Revenue in Nanoparticle Drug Delivery Systems Business (2019-2024) & (US$ Million)
Table 55. Sun Pharmaceutical Recent Development
Table 56. CSPC Company Detail
Table 57. CSPC Business Overview
Table 58. CSPC Nanoparticle Drug Delivery Systems Product
Table 59. CSPC Revenue in Nanoparticle Drug Delivery Systems Business (2019-2024) & (US$ Million)
Table 60. CSPC Recent Development
Table 61. Kinyond Company Detail
Table 62. Kinyond Business Overview
Table 63. Kinyond Nanoparticle Drug Delivery Systems Product
Table 64. Kinyond Revenue in Nanoparticle Drug Delivery Systems Business (2019-2024) & (US$ Million)
Table 65. Kinyond Recent Development
Table 66. Teva Company Detail
Table 67. Teva Business Overview
Table 68. Teva Nanoparticle Drug Delivery Systems Product
Table 69. Teva Revenue in Nanoparticle Drug Delivery Systems Business (2019-2024) & (US$ Million)
Table 70. Teva Recent Development
Table 71. Fudan-Zhangjiang Company Detail
Table 72. Fudan-Zhangjiang Business Overview
Table 73. Fudan-Zhangjiang Nanoparticle Drug Delivery Systems Product
Table 74. Fudan-Zhangjiang Revenue in Nanoparticle Drug Delivery Systems Business (2019-2024) & (US$ Million)
Table 75. Fudan-Zhangjiang Recent Development
Table 76. Zydus Cadila Company Detail
Table 77. Zydus Cadila Business Overview
Table 78. Zydus Cadila Nanoparticle Drug Delivery Systems Product
Table 79. Zydus Cadila Revenue in Nanoparticle Drug Delivery Systems Business (2019-2024) & (US$ Million)
Table 80. Zydus Cadila Recent Development
Table 81. TTY Biopharma Company Detail
Table 82. TTY Biopharma Business Overview
Table 83. TTY Biopharma Nanoparticle Drug Delivery Systems Product
Table 84. TTY Biopharma Revenue in Nanoparticle Drug Delivery Systems Business (2019-2024) & (US$ Million)
Table 85. TTY Biopharma Recent Development
Table 86. Pacira Company Detail
Table 87. Pacira Business Overview
Table 88. Pacira Nanoparticle Drug Delivery Systems Product
Table 89. Pacira Revenue in Nanoparticle Drug Delivery Systems Business (2019-2024) & (US$ Million)
Table 90. Pacira Recent Development
Table 91. Luye Pharma Company Detail
Table 92. Luye Pharma Business Overview
Table 93. Luye Pharma Nanoparticle Drug Delivery Systems Product
Table 94. Luye Pharma Revenue in Nanoparticle Drug Delivery Systems Business (2019-2024) & (US$ Million)
Table 95. Luye Pharma Recent Development
Table 96. Leadiant Biosciences Company Detail
Table 97. Leadiant Biosciences Business Overview
Table 98. Leadiant Biosciences Nanoparticle Drug Delivery Systems Product
Table 99. Leadiant Biosciences Revenue in Nanoparticle Drug Delivery Systems Business (2019-2024) & (US$ Million)
Table 100. Leadiant Biosciences Recent Development
Table 101. Ipsen Company Detail
Table 102. Ipsen Business Overview
Table 103. Ipsen Nanoparticle Drug Delivery Systems Product
Table 104. Ipsen Revenue in Nanoparticle Drug Delivery Systems Business (2019-2024) & (US$ Million)
Table 105. Ipsen Recent Development
Table 106. Sayre Therapeutics Company Detail
Table 107. Sayre Therapeutics Business Overview
Table 108. Sayre Therapeutics Nanoparticle Drug Delivery Systems Product
Table 109. Sayre Therapeutics Revenue in Nanoparticle Drug Delivery Systems Business (2019-2024) & (US$ Million)
Table 110. Sayre Therapeutics Recent Development
Table 111. Jazz Company Detail
Table 112. Jazz Business Overview
Table 113. Jazz Nanoparticle Drug Delivery Systems Product
Table 114. Jazz Revenue in Nanoparticle Drug Delivery Systems Business (2019-2024) & (US$ Million)
Table 115. Jazz Recent Development
Table 116. Alnylam Company Detail
Table 117. Alnylam Business Overview
Table 118. Alnylam Nanoparticle Drug Delivery Systems Product
Table 119. Alnylam Revenue in Nanoparticle Drug Delivery Systems Business (2019-2024) & (US$ Million)
Table 120. Alnylam Recent Development
Table 121. Bausch Health Company Detail
Table 122. Bausch Health Business Overview
Table 123. Bausch Health Nanoparticle Drug Delivery Systems Product
Table 124. Bausch Health Revenue in Nanoparticle Drug Delivery Systems Business (2019-2024) & (US$ Million)
Table 125. Bausch Health Recent Development
Table 126. Acrotech Biopharma Company Detail
Table 127. Acrotech Biopharma Business Overview
Table 128. Acrotech Biopharma Nanoparticle Drug Delivery Systems Product
Table 129. Acrotech Biopharma Revenue in Nanoparticle Drug Delivery Systems Business (2019-2024) & (US$ Million)
Table 130. Acrotech Biopharma Recent Development
Table 131. Takeda Company Detail
Table 132. Takeda Business Overview
Table 133. Takeda Nanoparticle Drug Delivery Systems Product
Table 134. Takeda Revenue in Nanoparticle Drug Delivery Systems Business (2019-2024) & (US$ Million)
Table 135. Takeda Recent Development
Table 136. Chiesi Farmaceutici Company Detail
Table 137. Chiesi Farmaceutici Business Overview
Table 138. Chiesi Farmaceutici Nanoparticle Drug Delivery Systems Product
Table 139. Chiesi Farmaceutici Revenue in Nanoparticle Drug Delivery Systems Business (2019-2024) & (US$ Million)
Table 140. Chiesi Farmaceutici Recent Development
Table 141. Gilead Sciences Company Detail
Table 142. Gilead Sciences Business Overview
Table 143. Gilead Sciences Nanoparticle Drug Delivery Systems Product
Table 144. Gilead Sciences Revenue in Nanoparticle Drug Delivery Systems Business (2019-2024) & (US$ Million)
Table 145. Gilead Sciences Recent Development
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Nanoparticle Drug Delivery Systems Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Nanoparticle Drug Delivery Systems Market Share by Type: 2023 VS 2030
Figure 3. Liposomes Drugs Features
Figure 4. Lipid Nanoparticle Drugs Features
Figure 5. Global Nanoparticle Drug Delivery Systems Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Nanoparticle Drug Delivery Systems Market Share by Application: 2023 VS 2030
Figure 7. Hospital Case Studies
Figure 8. Retail Pharmacy Case Studies
Figure 9. Other Case Studies
Figure 10. Nanoparticle Drug Delivery Systems Report Years Considered
Figure 11. Global Nanoparticle Drug Delivery Systems Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Nanoparticle Drug Delivery Systems Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Nanoparticle Drug Delivery Systems Market Share by Region: 2023 VS 2030
Figure 14. Global Nanoparticle Drug Delivery Systems Market Share by Players in 2023
Figure 15. Global Top Nanoparticle Drug Delivery Systems Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nanoparticle Drug Delivery Systems as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Nanoparticle Drug Delivery Systems Revenue in 2023
Figure 17. North America Nanoparticle Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Nanoparticle Drug Delivery Systems Market Share by Country (2019-2030)
Figure 19. United States Nanoparticle Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Nanoparticle Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Nanoparticle Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Nanoparticle Drug Delivery Systems Market Share by Country (2019-2030)
Figure 23. Germany Nanoparticle Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Nanoparticle Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Nanoparticle Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Nanoparticle Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Nanoparticle Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Nanoparticle Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Nanoparticle Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Nanoparticle Drug Delivery Systems Market Share by Region (2019-2030)
Figure 31. China Nanoparticle Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Nanoparticle Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Nanoparticle Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Nanoparticle Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Nanoparticle Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Nanoparticle Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Nanoparticle Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Nanoparticle Drug Delivery Systems Market Share by Country (2019-2030)
Figure 39. Mexico Nanoparticle Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Nanoparticle Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Nanoparticle Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Nanoparticle Drug Delivery Systems Market Share by Country (2019-2030)
Figure 43. Turkey Nanoparticle Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Nanoparticle Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Johnson & Johnson Revenue Growth Rate in Nanoparticle Drug Delivery Systems Business (2019-2024)
Figure 46. Sun Pharmaceutical Revenue Growth Rate in Nanoparticle Drug Delivery Systems Business (2019-2024)
Figure 47. CSPC Revenue Growth Rate in Nanoparticle Drug Delivery Systems Business (2019-2024)
Figure 48. Kinyond Revenue Growth Rate in Nanoparticle Drug Delivery Systems Business (2019-2024)
Figure 49. Teva Revenue Growth Rate in Nanoparticle Drug Delivery Systems Business (2019-2024)
Figure 50. Fudan-Zhangjiang Revenue Growth Rate in Nanoparticle Drug Delivery Systems Business (2019-2024)
Figure 51. Zydus Cadila Revenue Growth Rate in Nanoparticle Drug Delivery Systems Business (2019-2024)
Figure 52. TTY Biopharma Revenue Growth Rate in Nanoparticle Drug Delivery Systems Business (2019-2024)
Figure 53. Pacira Revenue Growth Rate in Nanoparticle Drug Delivery Systems Business (2019-2024)
Figure 54. Luye Pharma Revenue Growth Rate in Nanoparticle Drug Delivery Systems Business (2019-2024)
Figure 55. Leadiant Biosciences Revenue Growth Rate in Nanoparticle Drug Delivery Systems Business (2019-2024)
Figure 56. Ipsen Revenue Growth Rate in Nanoparticle Drug Delivery Systems Business (2019-2024)
Figure 57. Sayre Therapeutics Revenue Growth Rate in Nanoparticle Drug Delivery Systems Business (2019-2024)
Figure 58. Jazz Revenue Growth Rate in Nanoparticle Drug Delivery Systems Business (2019-2024)
Figure 59. Alnylam Revenue Growth Rate in Nanoparticle Drug Delivery Systems Business (2019-2024)
Figure 60. Bausch Health Revenue Growth Rate in Nanoparticle Drug Delivery Systems Business (2019-2024)
Figure 61. Acrotech Biopharma Revenue Growth Rate in Nanoparticle Drug Delivery Systems Business (2019-2024)
Figure 62. Takeda Revenue Growth Rate in Nanoparticle Drug Delivery Systems Business (2019-2024)
Figure 63. Chiesi Farmaceutici Revenue Growth Rate in Nanoparticle Drug Delivery Systems Business (2019-2024)
Figure 64. Gilead Sciences Revenue Growth Rate in Nanoparticle Drug Delivery Systems Business (2019-2024)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
